Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2 2

Status

Recruiting 2Terminated 1Active not recruiting 1

Sponsor Class

OTHER 4NIH 1NETWORK 1

Study Type

Interventional 4

Sponsor

Cancer Type

Genitourinary 1Gastrointestinal 1Breast 1

Conditions

Urinary Bladder Neoplasms 1Radiation Injuries 1Mixed Tumor, Mesodermal 1Esophageal Squamous Cell Carcinoma 1Esophageal Neoplasms 1Breast Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 271Specimen Handling 266pembrolizumab 233Cyclophosphamide 219Radiotherapy 208Nivolumab 169Cisplatin 165Biopsy 152Carboplatin 145Radiosurgery 131fludarabine 125Blood Specimen Collection 120Gemcitabine 113Paclitaxel 109Surveys and Questionnaires 108Standard of Care 106venetoclax 97Dexamethasone 95Bevacizumab 93Radiation 87Rituximab 83Capecitabine 81Cytarabine 80Oxaliplatin 77Drug Therapy 76Doxorubicin 75Ipilimumab 74durvalumab 73fludarabine phosphate 70atezolizumab 69

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
OTHER × Lymph Node Excision × 90 days × Clear all
NCT04889924 2026-05-19

ADARNAT

Hospital Universitari de Bellvitge

Phase NA Recruiting
820 enrolled
Breast

Breast Neoplasms, Radiation Injuries

NCT01737619 2026-05-04

PET/CT and Lymph Node Mapping in Finding Lymph Node Metastasis in Patients With High-Risk Endometrial Cancer

M.D. Anderson Cancer Center

Phase NA Active not recruiting
101 enrolled 8 charts

Mixed Tumor, Mesodermal

NCT05581589 2026-04-27

Sacituzumab Govitecan Before Radical Cystectomy for the Treatment of Non-Urothelial Muscle Invasive Bladder Cancer

University of Washington

Phase 2 Terminated
4 enrolled 13 charts
Genitourinary

Urinary Bladder Neoplasms

NCT07519486 2026-04-15

INS-ESCC-CT

Sichuan University

Phase 2 Recruiting
118 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡